Publicaciones en las que colabora con Juan Manuel Duarte Pérez (45)

2019

  1. Cardiovascular effects of flavonoids

    Current Medicinal Chemistry, Vol. 26, Núm. 39, pp. 6991-7034

2017

  1. Gender differences in the effects of cardiovascular drugs

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 3, Núm. 3, pp. 163-182

2016

  1. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction

    Biochemical Pharmacology, Vol. 110-111, pp. 25-36

  2. Vascular and central activation of peroxisome proliferator-activated receptor-β attenuates angiotensin II-induced hypertension: Role of RGS-5

    Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 1, pp. 151-163

2015

  1. New antihypertensive drugs under development

    Current Medicinal Chemistry, Vol. 22, Núm. 3, pp. 305-342

2013

  1. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension

    Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631

2012

  1. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741

  2. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension

    Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79

  3. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation

    PLoS ONE, Vol. 7, Núm. 3

2011

  1. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743

  2. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

    British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348

  3. New therapeutic targets for the development of positive inotropic agents.

    Discovery medicine, Vol. 12, Núm. 66, pp. 381-392

  4. Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: Role of NADPH oxidase

    Clinical Science, Vol. 120, Núm. 8, pp. 321-333

2010

  1. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure

    Current Opinion in Investigational Drugs, Vol. 11, Núm. 9, pp. 1039-1047

  2. Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 35, pp. 15631-15636

  3. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats

    European Journal of Pharmacology, Vol. 627, Núm. 1-3, pp. 242-250

  4. Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation

    Atherosclerosis, Vol. 212, Núm. 1, pp. 78-85

2008

  1. Flavonoids and cardiovascular disease: Mechanisms involved in the cardioprotective effects of quercetin

    Polyphenols and Health: New and Recent Advances (Nova Science Publishers, Inc.), pp. 1-30

  2. The HERACLES cardiovascular network

    Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75

2007

  1. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta

    Journal of Nutrition, Vol. 137, Núm. 4, pp. 910-915